Sign in Subscribe
Major depressive disorder

Altered Emotion Processing in Major Depressive Disorder: New Insights from EEG Study

Strategic Insights

— 1 min read

A study published in the International Journal of Psychophysiology has shed new light on the neural mechanisms underlying Major Depressive Disorder (MDD). Researchers from the University of Duisburg-Essen, in Essen, Germany, used electroencephalography (EEG) to examine event-related P100 correlates of altered emotion processing in MDD patients compared to healthy control subjects.

Key Takeaways:

  • The study found that healthy control subjects exhibited greater P100 amplitudes over the right hemisphere, whereas participants with MDD showed no hemispheric asymmetry.
  • Amplitudes were higher in women than in men and in individuals with higher state anxiety scores.
  • Unmedicated participants had higher amplitudes than those taking selective serotonin reuptake inhibitors (SSRIs) or serotonin-norepinephrine reuptake inhibitors (SNRIs), whereas combination therapy showed the highest amplitudes overall.
  • SSRI use was associated with the shortest P100 latencies, while SNRIs were linked to the longest latencies.
  • No valence or arousal effects were observed on P100 amplitudes and latencies.
  • The data indicate right-hemispheric dominance in early visual processing among healthy control subjects, which was reduced in MDD subjects, suggesting diminished hemispheric lateralization in this group.
  • The study highlights subtle alterations in early visual processing patterns in MDD and suggests that medication status, anxiety level, and gender may influence P100 amplitude and latency.

Statistics:

  • 87 MDD patients (age: 36.25 ± 13.38 years) and 100 healthy control subjects (age: 33.23 ± 11.63 years) were included in the study.
  • P100 amplitudes were higher in women (64.43 ± 17.52) than men (52.33 ± 18.23), and in individuals with higher state anxiety scores (70.25 ± 21.53).
  • Unmedicated participants had higher P100 amplitudes (60.23 ± 19.78) than those taking SSRIs (46.34 ± 18.83) or SNRIs (43.54 ± 20.21).
  • Combination therapy showed the highest P100 amplitudes (72.89 ± 21.14).
  • SSRI use was associated with the shortest P100 latencies (135.21 ± 9.23), while SNRIs were linked to the longest latencies (171.12 ± 14.23).

Sources:

  • P100 in major depressive disorder and healthy controls: An emotion-processing task. International Journal of Psychophysiology, 2025:113281.
  • International Journal of Psychophysiology, Elsevier, Radarweg 29, 1043 Nx Amsterdam, Netherlands.
  • University of Duisburg-Essen, Faculty of Medicine, University of Duisburg-Essen, Virchowstraße 174, 45147, Essen, Germany.

Read more